review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1038/CGT.2016.48 |
P698 | PubMed publication ID | 27834360 |
P50 | author | Mohsen Mohammadi | Q54279945 |
Hamed Mirzaei | Q63675145 | ||
P2093 | author name string | S M Mousavi | |
M Goodarzi | |||
S Fadaei | |||
J Verdi | |||
E Fadaee | |||
L Saadatpour | |||
R Nassiri Mansour | |||
P2860 | cites work | Exosomes: vehicles for the transfer of toxic proteins associated with neurodegenerative diseases? | Q21129257 |
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 | ||
Advanced health biotechnologies in Thailand: redefining policy directions | Q21245493 | ||
MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma | Q21245708 | ||
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis | Q24604354 | ||
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion | Q24633772 | ||
Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer | Q24645528 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes | Q27320839 | ||
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
RNA-quality control by the exosome | Q28251052 | ||
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma | Q28261810 | ||
Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy | Q28279046 | ||
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 | ||
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma | Q30407637 | ||
Oncogenic effects of miR-10b in glioblastoma stem cells | Q30414066 | ||
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells | Q30428366 | ||
miR-195, miR-455-3p and miR-10a( *) are implicated in acquired temozolomide resistance in glioblastoma multiforme cells. | Q34113732 | ||
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 | ||
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme | Q34207182 | ||
Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines | Q34226918 | ||
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme | Q34262423 | ||
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma | Q34381578 | ||
MiR-328 expression is decreased in high-grade gliomas and is associated with worse survival in primary glioblastoma | Q34450679 | ||
The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells | Q34490171 | ||
Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer | Q34736348 | ||
MIR-451 and Imatinib mesylate inhibit tumor growth of Glioblastoma stem cells. | Q34819445 | ||
MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development | Q35036059 | ||
Body fluid derived exosomes as a novel template for clinical diagnostics | Q35054648 | ||
MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways | Q35149540 | ||
Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. | Q35672459 | ||
Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer | Q35858377 | ||
MicroRNA expression profiling identifies miR-328 regulates cancer stem cell-like SP cells in colorectal cancer | Q35859038 | ||
VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling | Q36127410 | ||
cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a | Q36300857 | ||
Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype | Q36544941 | ||
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients | Q36552755 | ||
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma | Q36560956 | ||
Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase | Q36792756 | ||
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma | Q37191655 | ||
Biological gene delivery vehicles: beyond viral vectors | Q37412239 | ||
Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration | Q37474338 | ||
MiR-328 promotes glioma cell invasion via SFRP1-dependent Wnt-signaling activation | Q37492137 | ||
MicroRNA involvement in glioblastoma pathogenesis | Q37518235 | ||
STAT3 regulation of glioblastoma pathogenesis. | Q37550760 | ||
MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications | Q37857375 | ||
Exosomes as nano-theranostic delivery platforms for gene therapy | Q38028323 | ||
Glioblastoma: from molecular pathology to targeted treatment | Q38128382 | ||
The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment | Q38631508 | ||
Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies | Q38660013 | ||
MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma | Q38676204 | ||
Curcumin: A new candidate for melanoma therapy? | Q38859978 | ||
Differential Effects of MicroRNAs on Glioblastoma Growth and Migration | Q39219681 | ||
MiR-24 regulates the proliferation and invasion of glioma by ST7L via β-catenin/Tcf-4 signaling | Q39247010 | ||
miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2. | Q39274141 | ||
MiR-410 regulates MET to influence the proliferation and invasion of glioma | Q39322020 | ||
MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. | Q39371347 | ||
MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status. | Q39528026 | ||
Interaction of hsa-miR-381 and glioma suppressor LRRC4 is involved in glioma growth | Q39571222 | ||
MiR-136 promotes apoptosis of glioma cells by targeting AEG-1 and Bcl-2. | Q39613855 | ||
Radiation-induced micro-RNA modulation in glioblastoma cells differing in DNA-repair pathways | Q39716770 | ||
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity | Q39776996 | ||
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA. | Q39812809 | ||
MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells | Q39896800 | ||
The Exosome Is Recruited to RNA Substrates through Specific Adaptor Proteins | Q40596532 | ||
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients | Q44273844 | ||
Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers | Q84564273 | ||
Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study | Q85217159 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | biomarker | Q864574 |
glioblastoma | Q282142 | ||
microRNA | Q310899 | ||
P304 | page(s) | 415-418 | |
P577 | publication date | 2016-11-11 | |
P1433 | published in | Cancer Gene Therapy | Q15763088 |
P1476 | title | Glioblastoma: exosome and microRNA as novel diagnosis biomarkers | |
P478 | volume | 23 |
Q39368829 | Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis. |
Q40072469 | Anoikis resistance and oncoviruses. |
Q39038155 | Anti-Atherosclerotic Effects of Vitamins D and E in Suppression of Atherogenesis |
Q91840508 | Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches |
Q52564605 | Chronic obstructive pulmonary disease: MicroRNAs and exosomes as new diagnostic and therapeutic biomarkers. |
Q60045517 | Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis |
Q47396804 | Design, expression and evaluation of novel chimeric protein constructed from colorectal tumor-associated antigen |
Q41928848 | Diet and cancer prevention: Dietary compounds, dietary MicroRNAs, and dietary exosomes. |
Q41557851 | Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts |
Q90657489 | Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications |
Q54966511 | Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity. |
Q33791231 | Exosomes: A Novel Strategy for Treatment and Prevention of Diseases |
Q39395324 | Exosomes: promising sacks for treating ischemic heart disease? |
Q64064460 | Expression of miR-26b in ovarian carcinoma tissues and its correlation with clinicopathology |
Q47711872 | Extracellular Vesicles and the Promise of Continuous Liquid Biopsies |
Q64052645 | Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma |
Q98159054 | Identification of glioblastoma-specific prognostic biomarkers via an integrative analysis of DNA methylation and gene expression |
Q58748866 | Inhibition of microRNA-299-5p sensitizes glioblastoma cells to temozolomide via the MAPK/ERK signaling pathway |
Q39157824 | Integrating liquid biopsies into the management of cancer |
Q92408819 | Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma |
Q39432344 | Mesenchymal stem cells: A new platform for targeting suicide genes in cancer. |
Q48095332 | MiR-21: A key player in glioblastoma pathogenesis. |
Q64880476 | MicroRNA-559 plays an inhibitory role in the malignant progression of glioblastoma cells by directly targeting metadherin. |
Q39375777 | MicroRNA: A novel target of curcumin in cancer therapy |
Q39076551 | MicroRNA: Relevance to stroke diagnosis, prognosis, and therapy |
Q39402059 | MicroRNAs in retinoblastoma: Potential diagnostic and therapeutic biomarkers. |
Q39090370 | MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer. |
Q90384864 | Microfluidic Exponential Rolling Circle Amplification for Sensitive microRNA Detection Directly from Biological Samples |
Q48157286 | Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome |
Q39202038 | NLRP3 inflammasome: Its regulation and involvement in atherosclerosis |
Q39329359 | Nanoparticles as new tools for inhibition of cancer angiogenesis |
Q39315148 | Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis. |
Q46556374 | Regulation of tumor-stroma interactions by the Unfolded Protein Response. |
Q93226940 | Role of RNA-binding proteins during the late stages of Flavivirus replication cycle |
Q98195525 | Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis |
Q91741329 | Roles of Non-Coding RNAs in Normal Human Brain Development, Brain Tumor, and Neuropsychiatric Disorders |
Q52646452 | Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme. |
Q39085428 | State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia |
Q39329517 | Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases. |
Q38789375 | Stroke in Women: Risk Factors and Clinical Biomarkers. |
Q39285733 | Therapeutic application of multipotent stem cells |
Q64319932 | Ultracentrifugation versus kit exosome isolation: nanoLC-MS and other tools reveal similar performance biomarkers, but also contaminations |
Search more.